At a glance
ClinicalIndex Comparison RecordN/ACompleted· 34 enrolled
Drug / intervention
MORE-VRother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Digital Therapeutic Development of Virtual Cognitive-Affective Training for Opioid Use Disorder
In Brief
A clinical study evaluating MORE-VR for Opioid-use Disorder. Completed, enrolled 34 participants across 1 site.
Detailed Summary
This is a Phase 1 trial that aims to establish the safety of MORE-VR, as well as to collect feasibility, usability, and engagement data, for patients receiving medications for opioid use disorder (mOUD).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpioid-use Disorder
CountriesUnited States
CollaboratorsBehaVR LLC, National Institute on Drug Abuse (NIDA)
Timeline
N/ACompletedFinished
20222023202420252026
First PostedSep 2021
Enrollment StartOct 2021
Primary CompletionApr 2022
Study CompletionJul 2022
TodayJul 2026
First PostedSep 5, 2021
Enrollment StartOct 4, 2021
Primary CompletionApr 1, 2022
Study CompletionJul 22, 2022
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 4.8 years ago
Interventions
MORE-VRother
Mindfulness-Oriented Recovery Enhancement therapy delivered over virtual reality.